Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2009-03-24
Product name
Zemplar Capsules
Product Synonyms
19-Nor-1-alpha; 25-dihydroxyvitamin D2; Zemplar (Paricalcitol) Capsules 1 mcg; Zemplar (Paricalcitol) Capsules 2 mcg; Zemplar (Paricalcitol) Capsules 4 mcg
Manufacturer Name
Abbott Laboratories
Emergency telephone
1(800) 424-9300 (in USA and Canada
Icons in SDS
Company Information
company name
Abbott Laboratories
Section 2
SECTION 2: Hazards identification
Emergency Overview: Soft elastic capsule (SEC). Colorless to pale yellow liquid. Odor: Not determined. The following hazards are associated with the active pharmaceutical ingredient in this product: Highly toxic by ingestion. Highly toxic by dermal contact. May irritate the eyes.
Principle Routes of Exposure
Oral: Yes Clinical Route Dermal: Yes (one or more components) Unlikely (normal use) Inhalation: Unlikely (normal use) Hazard Information: Ingestion Rating: Highly Toxic Skin Absorption Rating: Highly Toxic Inhalation Rating: Not determined. Corrosiveness Rating: Not determined. Skin Contact Rating: Not determined. Skin Sensitization Rating: Not determined. Eye Contact Rating Not determined. Target Organs: Bone , Female Reproductive System , Cardiovascular System . Carcinogenicity Rating: Ingredients Percent OSHA: NTP: IARC: ACGIH: Medium Chain Triglycerides 99 Not Listed Ethyl Alcohol 1 Not Listed Listed Not Listed Paricalcitol 0.001 - 0.006 Not Listed
NFPA Ratings
Health: 1 Fire: 1 Reactivity: 0 Signs and Symptoms: No signs and symptoms from occupational exposure are known. Clinical data suggests the following: headaches, incoordination, vomiting, nausea, constipation, fast heart rate, sleep, muscle weakness, loss of appetite, alterations in blood chemistry, drowsiness, electrolyte imbalances, flushing, lightsensitive eyes, nasal discharge, cardiac changes, metallic taste, stupor. Ingestion may result in the following: alterations in serum lipid concentrations, anorexia, pruritus, altered libido, bone and joint pain, hypercalcemia, hyperphosphatemia. Notes to Physician: Excessive repeated exposure to paracalcin may result in calcification of susceptible organs.
Medical Conditions Generally Aggravated by Exposure
No medical conditions aggravated by occupational exposure are known. Data suggest any preexisting ailments in the following organs: eyes, female reproductive system, cardiovascular system, bone. Hypersensitivity to the material and/or similar materials.
